DexCare
PrivateLast Round
Series C
Jun 21, 2023
Total Funding Raised
$145M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DexCare is a healthcare technology company that offers an access optimization platform to intelligently orchestrate health system capacity and digital demand across all lines of care.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Telemedicine, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DexCare Comparables
Compare DexCare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notable | 83% | |
| Luma Health | 82% | |
| Health Catalyst | 81% |
DexCare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 21, 2023 | ||||
| Series B | Jan 13, 2022 | ||||
| Series A | Mar 22, 2021 |
Key People
Founding team and executive leadership
DexCare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Series C, Series B, Series A |
| Kaiser Permanente Ventures | Series C, Series A, Series B |
| Frist Cressey Ventures | Series A, Series B, Series C |
| ICONIQ Growth | Series C |
| Allumia Ventures | Series C, Series A, Series B |
| SpringRock Ventures | Series C, Series A, Series B |
| Define Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 153% MoM, reaching 11.9K.
- Jul 15, 2026
Providence named as a new customer.
Recent news
Latest coverage and updates
- recognized_asOct 2, 2026
DexCare, Inc. ranked No. 1 for patient experience in KLAS's 2025 Emerging Solutions Top 20 report
- acquiresSep 22, 2026
DexCare, Inc. acquires Mila Health, Inc. on Oct 2nd '26
DexCare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DexCare's valuation, stock price, and market status.
Is DexCare a public or private company?
DexCare is a private company.
What is the current stock price of DexCare?
DexCare is a private company, so its shares have no public market price. Caplight tracks DexCare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DexCare worth (valuation)?
Valuation information for DexCare is not publicly available.
Can I buy DexCare stock?
DexCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DexCare's last funding round?
DexCare's most recent funding round was Series C on June 21, 2023.
Who are the main investors in DexCare?
Key investors in DexCare include Define Ventures, ICONIQ Growth, Leerink Transformation Partners, Transformation Capital.
Will DexCare IPO soon?
No public IPO plans have been announced for DexCare.
How can I track DexCare secondary market activity?
Caplight tracks bids, offers, and trades in DexCare's shares on secondary markets.